Stay Informed
Subscribe to receive safety alerts
By email | By RSS

What's New

Singulair (montelukast) - FDA provided updated information to its March 2008 Early Communication.
(Posted 01/13/2008)

Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor): Update of Safety Review - The FDA has completed its review of the final clinical study report of ENHANCE and issued an update.
(Posted 01/08/2009)

January 2009 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 01/07/2009)

Innohep (tinzaparin sodium injection) - [UPDATE] Dear Healthcare Professional letter issued re: increased risk of death in elderly patients with renal insufficiency.
(Posted 12/31/2008)

Stryker Custom Cranial Implant Kits - Class 1 recall because sterility cannot be assured.
(Posted 12/24/2008)

Hydromorphone HCl 2 mg Tablets - Nationwide recall of a single lot due to potential for oversized tablets.
(Posted 12/24/2008)

Weight Loss Pills - Products contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.
(Posted 12/22/2008)

Safety Information

Medical Product
Reporting

Educational Resources

 FDA MedWatch and Patient Safety

A self-learning tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting.